Kazia Therapeutics

About:

Kazia Therapeutics is an oncology focused biotechnology company.

Website: https://www.kaziatherapeutics.com/

Twitter/X: kaziatx

Description:

Kazia Therapeutics is an oncology focused biotechnology company, developing innovative anti-cancer drugs. Kazia Therapeutics collaborates with leading scientists, clinicians and investors around the world.

Total Funding Amount:

$10.1M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Hornsby, New South Wales, Australia

Founded Date:

1994-01-01

Contact Email:

info(AT)novogen.com

Founders:

Graham Kelly

Number of Employees:

11-50

Last Funding Date:

2023-12-01

IPO Status:

Public

Industries: